Multiple sclerosis drug may help with poor working memory: Study Dr. Kamal Kant Kohli26 Feb 2025 8:30 PM ISTFampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced...
AI may aid in the timely diagnosis of schizophrenia and bipolar disorder, suggests research Dr. Kamal Kant Kohli25 Feb 2025 9:00 PM ISTSchizophrenia and bipolar disorder are severe mental disorders that often manifest in early adulthood. Effective treatments exist, but they require an...
Machine Learning Model Predicts Schizophrenia More Accurately Than Bipolar Disorder: JAMA Dr Riya Dave24 Feb 2025 8:15 PM ISTA new study has found that machine learning algorithms can forecast the progression of schizophrenia and bipolar disorder from typical clinical...
Xanomeline and trospium chloride Improves Cognition in Schizophrenia With Baseline Impairments, reveals study Dr Riya Dave20 Jan 2025 9:30 PM ISTXanomeline and trospium chloride (KarXT), a novel M1/M4 muscarinic receptor agonist, significantly improves cognitive performance among patients with...
Boehringer Ingelheim's Schizophrenia Drug iclepertin Fails Phase 3 Trial Dr. Kamal Kant Kohli19 Jan 2025 8:15 PM ISTBoehringer Ingelheim announced that its schizophrenia drug, iclepertin, did not achieve statistically significant improvements in cognition or...
Alembic Pharma bags USFDA final approval for schizophrenia drug Brexpiprazole Ruchika Sharma15 Jan 2025 1:30 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA)...
JnJ to acquire Intra-Cellular Therapies for USD 14.6 billion Ruchika Sharma15 Jan 2025 11:30 AM ISTNew Brunswick: Johnson & Johnson and Intra-Cellular Therapies, Inc. have announced that they have entered into a definitive agreement under...
Schizophrenia and MDD causally linked to increased constipation risk, discovers study Dr. Shravani Dali22 Dec 2024 8:45 PM ISTSchizophrenia and MDD causally linked to increased constipation risk, discovers study published in the Clinical and Experimental...
L-Theanine Supplementation Promising in Reducing Symptoms of Schizophrenia, Anxiety, and ADHD: Review Medha Baranwal19 Dec 2024 8:30 PM ISTIran: A recent systematic review has highlighted the potential of L-theanine supplementation as an effective approach to improving symptoms in...
Xanomeline-trospium found efficacious among schizophrenia patients experiencing acute psychosis: JAMA Dr Riya Dave2 Dec 2024 9:00 PM ISTResearchers discovered that xanomeline-trospium, a new-generation antipsychotic devoid of D2 dopamine receptor blocking activity, has shown potency...
Study Reveals Connection Between Thyroid Hormones and Brain Changes in Violent Schizophrenia Medha Baranwal1 Dec 2024 9:15 PM ISTChina: New data reveals that schizophrenia patients exhibiting violent behavior had reduced gray matter volume in the left frontal pole and elevated...
Psychiatric Disorders Significantly Increase Risk of Sudden Cardiac Death, reveals research Dr Riya Dave22 Nov 2024 9:00 PM ISTResearchers have found that patients with psychiatric disorders have a significantly increased risk for sudden cardiac death (SCD) in all age groups...
